Building the biopharma company of the future

Developing New Categories of Medicine

Our goal is to improve and extend the lives of patients through the development of new categories of medicine

Exploring the Brain Immune Gut (BIG) Axis

Focused on the crosstalk and biological processes associated with the brain-immune-gut interface

Giving Life to Science

Our goal is to improve and extend the lives of patients

Moving Medicine Forward

Discovery Reinvented

Publications
Publications -2017-09-19
Gamma Delta T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation

CD4(+) T regulatory cells (T(regs)), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T(regs) were most abundant in the colonic mucosa.

Full Article

Publications -2017-09-19
The Gut’s Clostridium Cocktail

Specific components of the microbiota—the microorganisms that normally colonize the body—can affect disease progression in mouse models of arthritis, central nervous system inflammation, diabetes, intestinal inflammation, and obesity.

Full Article
Publications -2017-06-01
Video game training enhances cognitive control in older adults

Cognitive controlis defined by a set of neural processes that allow us to interact with our complex environment in a goal-directed manner.

FULL ARTICLE

Media Coverage
2018-02-16
CNBC: Opening Bell, February 15, 2018

Ringing today's opening bells are Goodrich Petroleum with Gil Goodrich, chairman and CEO, and Robert Turnham, president, at the NYSE, and resTORbio with Chen Schor, co-founder, president and CEO, and Dr. Joan Mannick, co-founder and CMO, at the Nasdaq.

FULL VIDEO

Media Coverage
2018-02-16
Oncologists tap the microbiome in bid to improve immunotherapy outcomes
Media Coverage
2018-02-02
A new sort of health app can do the job of drugs

Smartphones are increasingly delivering verified treatments for diabetes, addictions and ADHD

FULL ARTICLE